Biotech company Recursion Pharmaceuticals fetches $60 mln Series B
Salt Lake City-based Recursion Pharmaceuticals, a biotechnology company, has secured $60 million in Series B financing. Data Collective led the round.
3 October 2017•1 min read
Salt Lake City-based Recursion Pharmaceuticals, a biotechnology company, has secured $60 million in Series B financing. Data Collective led the round.
